AI Article Synopsis
- The study assessed 10 online medical texts for evidence reporting quality, content coverage, and update timeliness, using an 11-item evaluation scale.
- Quality scores varied significantly, with the top resource scoring 9 out of 11 and the lowest scoring 0, averaging 6.7.
- Coverage of selected medical topics ranged from 25% to 83%, while the time since last updates varied considerably, with some resources being updated every 3.5 months and others taking up to 29 months.
Article Abstract
Objective: To evaluate the quality of evidence reporting, breadth of coverage, and timeliness of content updating of 10 selected online medical texts.
Study Design And Setting: Each text was assessed for quality based on an 11-item scale, which included items related to editorial policy and updating, appraisal, and transparent incorporation of newly published clinical research and evidence-based guidelines. Breadth of coverage was determined by the percentage of 60 randomly selected International Classification of Diseases 10 (ICD-10) codes covered by each of the texts. The same 60 ICD-10 codes were used to obtain a sample of topic chapters for the assessment of timeliness of updates.
Results: Quality scores ranged from a high of 9 of 11 points (Clinical Evidence) to a low of 0 of 11 points (PEPID), with a mean score of 6.7. Breadth of coverage ranged from 83% of randomly selected topics covered (UpToDate) to 25% (Clinical Evidence), with 6 of 10 texts covering 60% or more; average coverage across all texts was 57%. Variability was also observed with regard to average time since last content update, ranging from 3.5 (DynaMed) to 29 months (First Consult), with an average time since update of 12.4 months.
Conclusion: No single resource was ideal and those seeking answers to clinical questions are well-advised not to rely solely on a single point-of-care product.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jclinepi.2012.05.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Call for Clarity: A Proposed Toolkit to Integrate Foundational Sciences into Pharmacy Curricula.
Am J Pharm Educ
December 2024
Department of Pharmaceutical, and Administrative Sciences, College of Pharmacy and Health Sciences, School of Pharmacy, Belmont University, 1900 Belmont Blvd, Mailstop 13200, Nashville, TN 37212. Electronic address:
The American College of Clinical Pharmacy (ACCP) Pharmacotherapy Didactic Curriculum Toolkit has been used across many schools of pharmacy to guide the depth and breadth of therapeutics coverage, but no counterpart for foundational science coverage in pharmacy education currently exists. Broad topic areas for the foundational sciences are outlined in Appendix 1 of the Accreditation Council for Pharmacy Education (ACPE) standards, but the standards lack specific direction with regards to foundational sciences content needed in the professional pharmacy curriculum. Faculty are therefore challenged to determine the depth and breadth of foundational sciences to meet educational standards within limited curricular space, often resulting in curricular hoarding and overload.
View Article and Find Full Text PDFArticle Synopsis
- The study evaluates a new meningococcal vaccine (MenABCWY) that combines components of the existing MenB vaccine (4CMenB) and the MenACWY vaccine, aiming to provide broad immunization against various meningococcal strains and ease vaccination schedules.
- Conducted as a phase 3 randomized trial across multiple countries, healthy participants aged 10-25 were assigned to receive different vaccine schedules to assess safety, immune response, and consistency of vaccine lots.
- The trial primarily focused on the immune response to MenB strains, comparing MenABCWY's effectiveness to 4CMenB and evaluating the consistency of immune responses among different production lots of the vaccines.
Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study.
Wellcome Open Res
December 2024
KEMRI-Wellcome Trust Research Programme, KILIFI, Coast, 230-80108, Kenya.
Background: Given the low levels of coronavirus disease 2019 (COVID-19) vaccine coverage in sub-Saharan Africa (sSA), despite high levels of natural severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) exposures, strategies for extending the breadth and longevity of naturally acquired immunity are warranted. Designing such strategies will require a good understanding of naturally acquired immunity.
Methods: We measured whole-spike immunoglobulin G (IgG) and spike-receptor binding domain (RBD) total immunoglobulins (Igs) on 585 plasma samples collected longitudinally over five successive time points within six months of COVID-19 diagnosis in 309 COVID-19 patients.
Characterizing the rates and patterns of germline mutations in the aye-aye ().
bioRxiv
November 2024
Center for Evolution and Medicine, School of Life Sciences, Arizona State University, Tempe, AZ, USA.
Given the many levels of biological variation in mutation rates observed to date in primates - spanning from species to individuals to genomic regions - future steps in our understanding of mutation rate evolution will be aided by both a greater breadth of species coverage across the primate clade, but also by a greater depth as afforded by an evaluation of multiple trios within individual species. In order to help bridge these gaps, we here present an analysis of a species representing one of the most basal splits on the primate tree (aye-ayes), combining whole-genome sequencing of seven parent-offspring trios from a three-generation pedigree with a novel computational pipeline that takes advantage of recently developed pan-genome graphs, thereby circumventing the application of (highly subjective) quality metrics that has previously been shown to result in notable differences in the detection of mutations, and ultimately estimates of mutation rates. This deep sampling has enabled both a detailed picture of parental age effects as well as sex dependency in mutation rates which we here compare with previously studied primates, but has also provided unique insights into the nature of genetic variation in one of the most endangered primates on the planet.
View Article and Find Full Text PDFAccessible viral metagenomics for public health and clinical domains with Jovian.
Sci Rep
October 2024
Viroscience, Erasmus University Medical Center, 3015GB, Rotterdam, The Netherlands.
The integration of next-generation sequencing into clinical diagnostics and surveillance initiatives is impeded by the lack of data analysis pipelines that align with privacy legislation and laboratory certification protocols. To address these challenges, we developed Jovian, an open-source, virus-focused, metagenomic analysis workflow for Illumina data. Jovian generates scaffolds enriched with pertinent annotations, including taxonomic classification, combined with metrics needed for quality assessment (coverage depth, average GC content, localization of open reading frames, minority single nucleotide polymorphisms), and incorporates host and disease metadata.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!